Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704909 | SCV000237301 | uncertain significance | not provided | 2019-06-13 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000546015 | SCV000643361 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-06-16 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001170603 | SCV001333192 | uncertain significance | Cardiomyopathy | 2019-04-05 | criteria provided, single submitter | clinical testing | |
New York Genome Center | RCV001704909 | SCV002764555 | uncertain significance | not provided | 2020-12-22 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002503729 | SCV002815967 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-07-21 | criteria provided, single submitter | clinical testing |